Sign in

CIK 0001088856

  • Large accelerated filer

CORCEPT THERAPEUTICS INC

Sign in to watch
Ticker
CORT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
770487658
Phone
+1 650-688-8803
Business address
101 REDWOOD SHORES PARKWAY, REDWOOD CITY, CA, 94065
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$28,491,788
in 15 filings, $25.2M under 10b5-1 plans

Net −$28,491,788. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-09-02 Mokari Atabak Chief Financial Officer Shares withheld for taxes −102 $113.38 $12K 16,304
2026-09-01 Mokari Atabak Chief Financial Officer Grant or award +138 $113.38 $16K 16,268
2026-09-01 Mokari Atabak Chief Financial Officer Grant or award +138 16,406
2026-07-30 Mokari Atabak Chief Financial Officer Exercise or conversion 10b5-1 +80,000 $23.06 $1.8M 96,130
2026-07-30 Mokari Atabak Chief Financial Officer Sale 10b5-1 −4,200 $105.54 $443K 91,930
2026-07-30 Mokari Atabak Chief Financial Officer Sale 10b5-1 −8,956 $106.96 $958K 82,974
2026-07-30 Mokari Atabak Chief Financial Officer Sale 10b5-1 −400 $108.46 $43K 82,574
2026-07-30 Mokari Atabak Chief Financial Officer Sale 10b5-1 −2,202 $110.03 $242K 80,372
2026-07-30 Mokari Atabak Chief Financial Officer Sale 10b5-1 −600 $110.95 $67K 79,772
2026-07-30 Mokari Atabak Chief Financial Officer Sale 10b5-1 −4,700 $113.18 $532K 75,072
2026-07-30 Mokari Atabak Chief Financial Officer Sale 10b5-1 −15,477 $114.96 $1.8M 59,595
2026-07-30 Mokari Atabak Chief Financial Officer Sale 10b5-1 −14,222 $115.87 $1.6M 45,373
2026-07-30 Mokari Atabak Chief Financial Officer Sale 10b5-1 −7,089 $116.96 $829K 38,284
2026-07-30 Mokari Atabak Chief Financial Officer Sale 10b5-1 −8,267 $117.93 $975K 30,017
2026-07-30 Mokari Atabak Chief Financial Officer Sale 10b5-1 −4,783 $118.73 $568K 25,234
2026-07-30 Mokari Atabak Chief Financial Officer Sale 10b5-1 −8,103 $119.95 $972K 17,131
2026-07-30 Mokari Atabak Chief Financial Officer Sale 10b5-1 −1,001 $120.67 $121K 16,130
2026-07-30 Mokari Atabak Chief Financial Officer Exercise or conversion · Stock option (right to buy) 10b5-1 −80,000 95,833
2026-07-15 Mokari Atabak Chief Financial Officer Exercise or conversion 10b5-1 +15,833 $19.26 $305K 31,963
2026-07-15 Mokari Atabak Chief Financial Officer Exercise or conversion 10b5-1 +24,167 $23.06 $557K 56,130

Page 1 of 5 · 81 trades